Difference between revisions of "Talk:ABCC2"

From Libre Pathology
Jump to navigation Jump to search
(→‎Abstract: new section)
 
 
Line 1: Line 1:
== Abstract ==
== Abstract ==


''Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition'' - CKCis 2026
Castillo VF, Yacoub JM, Cornacchia K, Patel S, Mimosa M, Zakhary A, van der Kwast T, Trpkov K, Saleeb R, 2026, "Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition", Canadian Kidney Cancer Forum.

Latest revision as of 01:16, 19 May 2026

Abstract

Castillo VF, Yacoub JM, Cornacchia K, Patel S, Mimosa M, Zakhary A, van der Kwast T, Trpkov K, Saleeb R, 2026, "Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition", Canadian Kidney Cancer Forum.